BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

Breast Cancer Research and Treatment

Volumn 122, Issue 3, 2010, Pages 721-731

  Gorski, Julia J ^a   James, Colin R ^a   Quinn, Jennifer E ^a   Stewart, Gail E ^a   Staunton, Kieran Crosbie ^a   Buckley, Niamh E ^a   McDyer, Fionnuala A ^b   Kennedy, Richard D ^b   Wilson, Richard H ^a   Mullan, Paul B ^a   Harkin, D Paul ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Almac Sciences   (United Kingdom)

Author keywords

Basal like phenotype; BRCA1; Breast cancer; Transcription

Indexed keywords

BRCA1 PROTEIN; CYTOKERATIN 17; CYTOKERATIN 5; MESSENGER RNA; MYC PROTEIN; P CADHERIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; BRCA1 PROTEIN, HUMAN; CADHERIN; CDH3 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CELL LEVEL; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENETIC ASSOCIATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; WILD TYPE; ANTAGONISTS AND INHIBITORS; BASAL CELL CARCINOMA; BREAST TUMOR; CELL PROLIFERATION; DNA MICROARRAY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CADHERINS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-17; KERATIN-5; NEOPLASMS, BASAL CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 77955558521     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0565-0     Document Type: Article

References (25)

1. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10963602
2. WD Foulkes PO Chappuis N Wong JS Brunet D Vesprini F Rozen ZQ Yuan MN Pollak G Kuperstein SA Narod LR Begin 2000 Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome Ann Oncol 11 307 313 10.1023/A:1008340723974 1:STN:280:DC%2BD3c3mvFKgtg%3D%3D 10811497 (Pubitemid 30214668)
3. WD Foulkes IM Stefansson PO Chappuis LR Begin JR Goffin N Wong M Trudel LA Akslen 2003 Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 1482 1485 1:CAS:528:DC%2BD3sXnvVCjtrk%3D 14519755
4. WD Foulkes JS Brunet IM Stefansson O Straume PO Chappuis LR Begin N Hamel JR Goffin N Wong M Trudel L Kapusta P Porter LA Akslen 2004 The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid- microvascular-proliferation+) phenotype of BRCA1-related breast cancer Cancer Res 64 830 835 10.1158/0008-5472.CAN-03-2970 1:CAS:528:DC%2BD2cXhtFCgtLo%3D 14871808 (Pubitemid 38176880)
5. JB Arnes JS Brunet I Stefansson LR Begin N Wong PO Chappuis LA Akslen WD Foulkes 2005 Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer Clin Cancer Res 11 4003 4011 10.1158/1078-0432.CCR- 04-2064 1:CAS:528:DC%2BD2MXks1Gksr8%3D 15930334 (Pubitemid 40791563)
6. J Palacios E Honrado A Osorio A Cazorla D Sarrio A Barroso S Rodriguez JC Cigudosa O Diez C Alonso E Lerma J Dopazo C Rivas J Benitez 2005 Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers Breast Cancer Res Treat 90 5 14 10.1007/s10549-004-1536-0 1:CAS:528:DC%2BD2MXit1Olur4%3D 15770521 (Pubitemid 40486996)
7. SR Lakhani J Jacquemier JP Sloane BA Gusterson TJ Anderson MJ van de Vijver LM Farid D Venter A Antoniou A Storfer-Isser E Smyth CM Steel N Haites RJ Scott D Goldgar S Neuhausen PA Daly W Ormiston R McManus S Scherneck BA Ponder D Ford J Peto D Stoppa-Lyonnet DF Easton, et al. 1998 Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1138 1145 10.1093/jnci/90.15.1138 1:CAS:528:DyaK1cXlsVOrs78%3D 9701363
8. SR Lakhani MJ O'Hare A Ashworth 2001 Profiling familial breast cancer Nat Med 7 408 410 10.1038/86464 1:CAS:528:DC%2BD3MXis1ylsrw%3D 11283660 (Pubitemid 32298536)
9. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D 12829800 (Pubitemid 36842560)
10. TA Grushko JJ Dignam S Das AM Blackwood CM Perou KK Ridderstrale KN Anderson MJ Wei AJ Adams FG Hagos L Sveen HT Lynch BL Weber OI Olopade 2004 MYC is amplified in BRCA1-associated breast cancers Clin Cancer Res 10 499 507 10.1158/1078-0432.CCR-0976-03 1:CAS:528:DC%2BD2cXovVGrtg%3D%3D 14760071 (Pubitemid 38173988)
11. H Li TH Lee H Avraham 2002 A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer J Biol Chem 277 20965 20973 10.1074/jbc.M112231200 1:CAS:528:DC%2BD38XkslWnsLk%3D 11916966 (Pubitemid 34967407)
12. Y Li J Pan JL Li JH Lee C Tunkey K Saraf JC Garbe MZ Whitley SA Jelinsky MR Stampfer SA Haney 2007 Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized Mol Cancer 6 7 10.1186/1476-4598-6-7 17233903
13. RD Kennedy JJ Gorski JE Quinn GE Stewart CR James S Moore K Mulligan ED Emberley TF Lioe PJ Morrison PB Mullan G Reid PG Johnston PH Watson DP Harkin 2005 BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene Cancer Res 65 10265 10272 10.1158/0008-5472.CAN-05-1841 1:CAS:528:DC%2BD2MXht1WgurfM 16288014 (Pubitemid 41743718)
14. AM Hosey JJ Gorski MM Murray JE Quinn WY Chung GE Stewart CR James SM Farragher JM Mulligan AN Scott PA Dervan PG Johnston FJ Couch PA Daly E Kay A McCann PB Mullan DP Harkin 2007 Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer J Natl Cancer Inst 99 1683 1694 10.1093/jnci/djm207 1:CAS:528:DC%2BD1cXkslyluw%3D%3D 18000219 (Pubitemid 351767217)
15. L Weng H Dai Y Zhan Y He SB Stepaniants DE Bassett 2006 Rosetta error model for gene expression analysis Bioinformatics 22 1111 1121 10.1093/bioinformatics/btl045 1:CAS:528:DC%2BD28XjslKrsbg%3D 16522673
16. JE Quinn RD Kennedy PB Mullan PM Gilmore M Carty PG Johnston DP Harkin 2003 BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis Cancer Res 63 6221 6228 1:CAS:528:DC%2BD3sXotV2jur0%3D 14559807
17. F Elstrodt A Hollestelle JH Nagel M Gorin M Wasielewski A van den Ouweland SD Merajver SP Ethier M Schutte 2006 BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants Cancer Res 66 41 45 10.1158/0008-5472.CAN-05-2853 1:CAS:528:DC%2BD28XhsFWmtw%3D%3D 16397213 (Pubitemid 43166006)
18. SR Lakhani JS Reis-Filho L Fulford F Penault-Llorca M van der Vijver S Parry T Bishop J Benitez C Rivas YJ Bignon J Chang-Claude U Hamann CJ Cornelisse P Devilee MW Beckmann C Nestle-Kramling PA Daly N Haites J Varley F Lalloo G Evans C Maugard H Meijers-Heijboer JG Klijn E Olah BA Gusterson S Pilotti P Radice S Scherneck H Sobol J Jacquemier T Wagner J Peto MR Stratton L McGuffog DF Easton 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 5175 5180 10.1158/1078-0432.CCR-04-2424 1:CAS:528:DC%2BD2MXmt12qtbk%3D 16033833 (Pubitemid 41003703)
19. RM Neve K Chin J Fridlyand J Yeh FL Baehner T Fevr L Clark N Bayani JP Coppe F Tong T Speed PT Spellman S DeVries A Lapuk NJ Wang WL Kuo JL Stilwell D Pinkel DG Albertson FM Waldman F McCormick RB Dickson MD Johnson M Lippman S Ethier A Gazdar JW Gray 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 515 527 10.1016/j.ccr.2006.10.008 1:CAS:528:DC%2BD28XhtlCnsrbE 17157791 (Pubitemid 44854747)
20. PB Mullan JE Quinn DP Harkin 2006 The role of BRCA1 in transcriptional regulation and cell cycle control Oncogene 25 5854 5863 10.1038/sj.onc.1209872 1:CAS:528:DC%2BD28XhtVSgurvE 16998500 (Pubitemid 44453441)
21. M Laakso N Loman A Borg J Isola 2005 Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors Mod Pathol 18 1321 1328 10.1038/modpathol.3800456 1:CAS:528:DC%2BD2MXhtVWiu7fI 15990899 (Pubitemid 41348650)
22. NC Turner JS Reis-Filho AM Russell RJ Springall K Ryder D Steele K Savage CE Gillett FC Schmitt A Ashworth AN Tutt 2007 BRCA1 dysfunction in sporadic basal-like breast cancer Oncogene 26 2126 2132 10.1038/sj.onc.1210014 1:CAS:528:DC%2BD2sXjsFSiu7c%3D 17016441 (Pubitemid 46514749)
23. S Abramovitch T Glaser T Ouchi H Werner 2003 BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene FEBS Lett 541 149 154 10.1016/S0014-5793(03)00315-6 1:CAS:528:DC%2BD3sXjtFWrtL0%3D 12706836 (Pubitemid 36428934)
24. Q Wang H Zhang K Kajino MI Greene 1998 BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells Oncogene 17 1939 1948 10.1038/sj.onc.1202403 1:CAS:528:DyaK1cXnt1Gltrg%3D 9788437
25. J Palacios MJ Robles-Frias MA Castilla MA Lopez-Garcia J Benitez 2008 The molecular pathology of hereditary breast cancer Pathobiology 75 85 94 10.1159/000123846 1:STN:280:DC%2BD1czns1yjug%3D%3D 18544963 (Pubitemid 351820726)